+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
Protein Inhibitors Market Report 2025 - Product Thumbnail Image

Protein Inhibitors Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Toll-like Receptor 9 (TLR-9) Modulator - Pipeline Insight, 2025 - Product Thumbnail Image

Toll-like Receptor 9 (TLR-9) Modulator - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
From
Orphan Drugs Market 2024-2028 - Product Thumbnail Image

Orphan Drugs Market 2024-2028

  • Report
  • August 2024
  • 180 Pages
  • Global
From
Alpha Mannosidosis Market Report 2025 - Product Thumbnail Image

Alpha Mannosidosis Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Competitive landscape, 2025 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive landscape, 2025

  • Report
  • April 2025
  • 400 Pages
  • Global
From
Exocrine Pancreatic Insufficiency Market Report 2025 - Product Thumbnail Image

Exocrine Pancreatic Insufficiency Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Crohn's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Crohn's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
From
Acromegaly Market Report 2025 - Product Thumbnail Image

Acromegaly Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
DNA Repair Drugs: Global Markets - Product Thumbnail Image

DNA Repair Drugs: Global Markets

  • Report
  • February 2022
  • 112 Pages
  • Global
From
Acetyl-CoA Carboxylase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Acetyl-CoA Carboxylase Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Loading Indicator